Cargando…
Distinctive and common features of moderate aplastic anaemia
The therapy algorithm for severe aplastic anaemia (sAA) is established but moderate AA (mAA), which likely reflects a more diverse pathogenic mechanism, often represents a treatment/management conundrum. A cohort of AA patients (n = 325) was queried for those with non‐severe disease using stringent...
Autores principales: | Patel, Bhumika J., Barot, Shimoli V., Kuzmanovic, Teodora, Kerr, Cassandra, Przychodzen, Bartlomiej P., Thota, Swapna, Lee, Sarah, Patel, Saurabh, Radivoyevitch, Tomas, Lichtin, Alan, Advani, Anjali, Kalaycio, Matt, Sekeres, Mikkael A., Carraway, Hetty E., Maciejewski, Jaroslaw P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340733/ https://www.ncbi.nlm.nih.gov/pubmed/32004386 http://dx.doi.org/10.1111/bjh.16460 |
Ejemplares similares
-
Deficit of circulating CD19(+)CD24(hi)CD38(hi) regulatory B cells in severe aplastic anaemia
por: Zaimoku, Yoshitaka, et al.
Publicado: (2020) -
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open‐label study
por: Jang, Jun Ho, et al.
Publicado: (2020) -
Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML
por: Przychodzen, Bartlomiej, et al.
Publicado: (2017) -
Molecular features of early onset adult myelodysplastic syndrome
por: Hirsch, Cassandra M., et al.
Publicado: (2017) -
Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasms
por: Visconte, Valeria, et al.
Publicado: (2016)